AIM
ACXP icon

Anchor Investment Management’s Acurx Pharmaceuticals ACXP Stock Holding History

Anchor Investment Management’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-225
Closed -$6.75K – 953
2023
Q3 		$6.75K Buy
+225
New +$8.61K ﹤0.01% 802

Other funds holding ACXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Anchor Investment Management's ACXP Position: Q4 2023 in Review

Anchor Investment Management sold out of Acurx Pharmaceuticals (ACXP) in Q4 2023, closing a stake of 225 shares — an estimated $6.75K sold.

Anchor Investment Management first reported a position in ACXP in Q3 2023 and held it in 1 quarter. The position peaked at $6.75K in Q3 2023. 23 funds tracked by Wall St. Rank hold ACXP as of Q4 2023.

  • Anchor Investment Management reported no remaining Acurx Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Anchor Investment Management sold 225 Acurx Pharmaceuticals shares in Q4 2023, an estimated $6.75K.
  • Anchor Investment Management first reported a position in Acurx Pharmaceuticals in Q3 2023 and held it in 1 quarter.
  • Anchor Investment Management's Acurx Pharmaceuticals position peaked at $6.75K in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q4 2023.

Based on Anchor Investment Management's 13F filing for Q4 2023, filed 2 Jan 2024.